1. Prostate Cancer 2008: Challenges in Diagnosis and Management
Michael Marberger 
European Urology Supplements 
Volume 8, Issue 3, Pages (January 2009)
DOI: /j.eursup
Copyright © 2008 European Association of Urology Terms and Conditions

2. Fig. 1
Age standardized incidence and mortality rates from 2002 to 2004 as documented in cancer registries in 19 European countries (figures not always representative for the entire population of the country) [6].
European Urology Supplements 2009 8, 89-96DOI: ( /j.eursup )
Copyright © 2008 European Association of Urology Terms and Conditions

3. Fig. 2
Prostate cancer detected at routine sextant biopsy in men in the placebo arm of the Prostate Cancer Prevention Trial, with negative digital rectal examination and serum prostate-specific antigen <4ng/ml [18].
European Urology Supplements 2009 8, 89-96DOI: ( /j.eursup )
Copyright © 2008 European Association of Urology Terms and Conditions

4. Fig. 3
The molecular pathogenesis of prostate cancer segregated into non–androgen-sensitive versus androgen-sensitive. Reproduced with permission from Lippincott Williams & Wilkins [30].
European Urology Supplements 2009 8, 89-96DOI: ( /j.eursup )
Copyright © 2008 European Association of Urology Terms and Conditions